Healthy Living South Dakota: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living South Dakota.

Press releases published on May 29, 2026

National Nursing Organizations File Nurse-Forward Lawsuit Against the Department of Education Over Professional Degree Designation
Renown Jazz Artists Hit the Stage to Help Georgians Receive Healthcare
Celularity Receives Nasdaq Notice Regarding Form 10-Q
Kane Biotech Announces Grant of Stock Options
Quest PharmaTech Provides Corporate Update including Voluntary Adoption of CSA Blanket Order 51-93 to File Financial Statements and MD&A on Semi-Annual Basis
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Crescent Biopharma Announces Grants of Inducement Awards
Jade Biosciences to Host Conference Call and Webcast on June 1, 2026, at 8:00 a.m. ET to Discuss Interim Phase 1 Healthy Volunteer Results for JADE101, a Novel, Potentially Best-in-Class Anti-APRIL Monoclonal Antibody in Development for IgA Nephropathy
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences
Arvinas to Present at Jefferies Global Healthcare Conference
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
Oculis Announces Topline Results from DIAMOND Phase 3 Trials with OCS-01 in Diabetic Macular Edema
ASAP Dental Care Expands Evening and Weekend Hours Across Greater Jacksonville to Meet Urgent Dental and Emergency Needs
MannKind to Host Conference Call Today to Discuss Afrezza Pediatric Approval
FDA Issues Draft Guidance to Cut Unnecessary Animal Testing for Cancer Drugs
Kun Peng International Ltd. Announces 1-for-10 Reverse Stock Split
Dr. Matthew T. Provencher Receives Prestigious  2026 Stephen S. Burkhart Shoulder Innovation Research Award
MannKind Announces FDA Approval of Afrezza®, the First and Only Inhaled Mealtime Insulin for Use in Children and Adolescents Aged 6 and Older Living with Diabetes
The Next Great AI Revolution May Be Drug Delivery

Share this page:

Sign up for:

Healthy Living South Dakota

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.